Pacira Biosciences, Inc. (PCRX)
24.96
+0.10
(+0.40%)
USD |
NASDAQ |
Aug 25, 11:32
Pacira Biosciences Market Cap : 993.96M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 989.98M |
| August 21, 2026 | 982.42M |
| August 20, 2026 | 948.97M |
| August 19, 2026 | 970.07M |
| August 18, 2026 | 955.74M |
| August 17, 2026 | 925.47M |
| August 14, 2026 | 915.91M |
| August 13, 2026 | 923.08M |
| August 12, 2026 | 943.79M |
| August 11, 2026 | 970.87M |
| August 10, 2026 | 972.86M |
| August 07, 2026 | 996.35M |
| August 06, 2026 | 1.019B |
| August 05, 2026 | 990.38M |
| August 04, 2026 | 1.100B |
| August 03, 2026 | 1.072B |
| July 31, 2026 | 1.038B |
| July 30, 2026 | 1.060B |
| July 29, 2026 | 1.038B |
| July 28, 2026 | 1.054B |
| July 27, 2026 | 1.041B |
| July 24, 2026 | 1.017B |
| July 23, 2026 | 1.019B |
| July 22, 2026 | 1.006B |
| July 21, 2026 | 1.013B |
| Date | Value |
|---|---|
| July 20, 2026 | 996.50M |
| July 17, 2026 | 1.007B |
| July 16, 2026 | 1.006B |
| July 15, 2026 | 995.71M |
| July 14, 2026 | 983.13M |
| July 13, 2026 | 1.004B |
| July 10, 2026 | 1.002B |
| July 09, 2026 | 1.002B |
| July 08, 2026 | 1.003B |
| July 07, 2026 | 1.015B |
| July 06, 2026 | 1.006B |
| July 02, 2026 | 998.07M |
| July 01, 2026 | 983.92M |
| June 30, 2026 | 997.28M |
| June 29, 2026 | 986.28M |
| June 26, 2026 | 992.17M |
| June 25, 2026 | 957.98M |
| June 24, 2026 | 941.86M |
| June 23, 2026 | 924.17M |
| June 22, 2026 | 892.72M |
| June 18, 2026 | 877.78M |
| June 17, 2026 | 889.97M |
| June 16, 2026 | 897.05M |
| June 15, 2026 | 893.90M |
| June 12, 2026 | 903.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zimmer Biomet Holdings, Inc. | 19.01B |
| Liquidia Corp. | 6.323B |
| Johnson & Johnson | 658.36B |
| Merck & Co., Inc. | 381.38B |
| ANI Pharmaceuticals, Inc. | 1.698B |
Market Cap Related Metrics
| PE Ratio | 71.91 |
| PS Ratio | 1.410 |
| Price to Book Value | 1.479 |
| Price to Free Cash Flow | 5.862 |
| Price | 24.96 |
| Earnings Yield | 1.39% |
| Operating PE Ratio | 38.09 |
| Normalized PE Ratio | 51.23 |